Apollo Cancer Centre Chennai

Apollo Cancer Centre Chennai holds JCI (Joint Commission International) accreditation, which can be confirmed through the accredited-organisations directory at jointcommissioninternational.org, and NABH (National Accreditation Board for Hospitals & Healthcare Providers) accreditation, verifiable at nabh.co/accredited-hospitals.aspx. Both accreditations were confirmed against primary sources on 2024-04-15. JCI accreditation for an oncology facility evaluates clinical care standards, infection control, medication management, and patient safety systems across the cancer pathway. Accreditation confirms systems are in place at the time of assessment; it does not constitute a guarantee of treatment outcomes.

A multidisciplinary tumour board (MTB) brings together medical oncologists, radiation oncologists, surgical oncologists, radiologists, and pathologists to review complex cases collectively before treatment decisions are made. Apollo Cancer Centre Chennai convenes weekly MTB meetings for new and complex cases. The MTB's role is to agree a treatment plan based on the full clinical picture rather than the perspective of a single specialty. International patients presenting with a new diagnosis or seeking a second opinion can request that their case be reviewed at the next scheduled MTB meeting; the outcome is documented and a treatment plan issued. Patients should ask the international patient coordinator how to submit records for MTB review.

The Indian Council of Medical Research (ICMR) publishes national clinical practice guidelines for the management of various cancer types. Apollo Cancer Centre Chennai, as a high-volume JCI-accredited oncology facility, operates within the framework of these guidelines. For many cancer types, the centre also references international guidelines from bodies such as ESMO (European Society for Medical Oncology) or NCCN (National Comprehensive Cancer Network), which patients may request. Patients should ask whether their proposed treatment protocol is aligned with current ICMR or ESMO/NCCN guidelines and request a written explanation of how the protocol was determined, particularly if targeted or immunotherapy agents are involved.

All oncologists at Apollo Cancer Centre Chennai must be registered with the National Medical Commission (NMC); their registration is searchable at nmc.org.in. Medical oncologists hold an MD (Internal Medicine) or MD (Oncology) as their primary postgraduate qualification, often supplemented by a DM (Medical Oncology) — the super-specialty qualification requiring a further three-year programme. Radiation oncologists hold an MD (Radiation Oncology). Surgical oncologists hold an MS followed by an MCh in Surgical Oncology. Patients are encouraged to request the consultant's name, NMC number, and postgraduate qualification details and verify these before committing to travel.

Apollo Cancer Centre Chennai, through Apollo's international patient services department, provides remote case review for patients with an existing diagnosis who wish to assess their current treatment plan. Patients submit pathology slides (or digital pathology reports), imaging studies, and clinical notes; these are reviewed by the relevant oncology sub-specialists and the findings communicated to the patient and their home-country physician. This review can recommend whether the proposed treatment aligns with the findings, suggest alternative protocols, or identify the need for additional diagnostic investigations. The process does not replace an in-person consultation but can inform a travel decision and establish a treatment plan in advance of arrival.

Apollo Cancer Centre Chennai's pharmacy stocks a range of targeted therapy and immunotherapy agents, including checkpoint inhibitors and monoclonal antibodies used in standard-of-care protocols for breast, lung, colorectal, and haematological cancers. The availability of specific agents depends on the current approved formulary and whether the agent holds marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) in India. Patients should ask whether a specific agent they have been prescribed abroad is available in India, and at what cost, before travelling. Some agents may be available at a different price point in India compared to the patient's home country, while others may not be on the formulary.

Apollo Cancer Centre operates within the Apollo Hospitals network in Chennai, providing immediate access to inpatient wards, intensive care units, and 24-hour emergency services on the same campus. Chemotherapy-related emergencies — including neutropenic sepsis, severe infusion reactions, and metabolic complications — are managed on-site by the oncology team with escalation to the ICU if required. The proximity of oncology day-unit infusion bays to inpatient beds and ICU capacity is a practical advantage of receiving chemotherapy at a hospital-based centre rather than a standalone clinic. Patients should confirm the emergency contact process for out-of-hours symptoms with their assigned care coordinator on arrival.

Apollo Cancer Centre Chennai does not publish oncology treatment prices publicly. Pricing for chemotherapy is highly variable depending on the drug regimen, the number of cycles, the route of administration, and any concurrent supportive medications. Written estimates are provided by the international patient services department and should itemise drug costs per cycle, administration fees, nursing and monitoring costs, and the cost of any required investigations (scans, tumour markers) during treatment. Patients should confirm whether the estimate is based on the currently proposed protocol and what the financial position is if the protocol changes due to response or toxicity. Total costs for a multi-cycle chemotherapy course can range widely; patients should request a per-cycle and total estimate.

Apollo Cancer Centre's international patient services department assigns a care coordinator who manages communication between the patient's home-country oncologist and the Apollo team. Scan results, laboratory reports, and treatment summaries are shared electronically, and video consultations with the treating oncologist can be arranged for response assessments and treatment adjustments. For patients undergoing multi-cycle chemotherapy, some monitoring cycles may be conducted in the home country under a shared-care protocol with the patient's local oncologist. Apollo does not maintain formal partner clinic networks in specific overseas countries, so patients must arrange local oncology support independently before starting treatment in India.

Apollo Cancer Centre Chennai operates English-language consultations as standard and Tamil-language services for domestic patients. The international patient services department provides coordination support in several languages and can arrange professional medical interpretation for patients who require it in another language. Patients from South Asia, the Middle East, and members of the Tamil diaspora represent a significant proportion of the international patient cohort, and the department has experience handling the documentation and logistics requirements for those regions. Patients seeking interpretation in less commonly spoken languages should notify the international patient services department several weeks in advance to confirm availability.